RPID · Rapid Micro Biosystems, Inc.
$2.01
+0.03 (+1.26%)
At close · Jul 27
Market Cap
$91.88M
Shares
46.17M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Robert G. Spignesi | CEO | $3,225,491 |
| Sean Wirtjes | CFO | $1,589,310 |
| John Wilson | COO | $1,062,736 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Robert G. Spignesi | CEO | $1,313,638 |
| Sean Wirtjes | CFO | $762,893 |
| John Wilson | COO | $725,767 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Robert G. Spignesi | CEO | $1,797,254 |
| John Wilson | COO | $957,949 |
| Sean Wirtjes | CFO | $923,838 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Robert G. Spignesi | CEO | $2,223,984 |
| John Wilson | COO | $1,410,104 |
| Sean Wirtjes | CFO | $1,096,542 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Richard Keys | Chief Commercial Officer | $1,637,678 |
| Robert G. Spignesi | CEO | $1,459,538 |
| John Wilson | COO | $1,220,591 |
| Sean Wirtjes | CFO | $670,093 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Robert G. Spignesi | CEO | $1,090,832 |
| Sean Wirtjes | CFO | $613,828 |